Trial NCT01545817

View at ClinicalTrials.gov 
Org. Study IDs: 114907

Last trial update was posted on 2019-10-09

MeSH Interventions

Everolimus

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions


Stopping Reasons

As the therapeutic landscape in renal cell carcinoma is changing, it has become apparent that information gained so far by CATChEz study is sufficient.

Limitations And Caveats

the trial terminated early because the information gained from this study was sufficient to meet the objectives for which the study had been set up and would be no longer clinically relevant for the second-line management of RCC patients.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID